Posted on 1/4/19
Catabasis Pharmaceuticals Appoints Gregg Lapointe to its Board of Directors
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the appointment of Gregg Lapointe to its Board of Directors.
Posted on 1/4/19
Ironwood Pharmaceuticals Appoints Mark Mallon and Peter Hecht
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that the Ironwood board of directors has appointed chief executive officers (CEOs) of the two companies, effective . . .
Posted on 1/4/19
Allena Pharmaceuticals Appoints Louis Brenner, M.D. as CEO
Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing
Posted on 1/4/19
Surface Oncology Appoints F. Stephen Hodi, MD To Its Scientific Advisory Board
CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced . . .
Posted on 1/4/19
SeriousFun Children's Network Names Maurice Pratt As Board Chair And Don Gogel As Vice Chair Of The Board Of Directors
The Board of Directors of SeriousFun Children's Network has named Maurice Pratt as Board Chair, with Don Gogel stepping into the role of Vice Chair.
Posted on 1/4/19
Katahdin Bankshares Corp. Appoints Marianna Putnam Liddell and Keith Bourgoin to Board
Katahdin Bankshares Corp. (OTCQX: KTHN), parent company of Katahdin Trust Company, a full-service community bank founded in 1918 serving Northern Maine
Posted on 1/4/19
Reputation Institute Names Vicki Raport to Board of Directors
Reputation Institute (RI), the world’s leading provider of reputation measurement, management and intelligence services, today announced the addition of Vicki Raport
Posted on 1/3/19
Arbor Biotechnologies Announces New Discoveries and Addition to its Board
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor), an early-stage life sciences company, today announced significant milestones including the discovery of multiple new . . .
Posted on 1/3/19
Stephen V. Kenney to Join Boston Financial Management as CEO
Stephen V. KenneyBoston Financial Management LLC, an independent and employee-owned wealth management and investment advisory firm, announces today the appointment of Stephen V. Kenney as President . . .
Posted on 1/3/19
Miach Orthopaedics Appoints Martha Shadan President and CEO
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue repair, today announced that medical device industry veteran . . .
Posted on 1/3/19
Translate Bio Appoints Robert Meyer, MD, to its Board of Directors
LEXINGTON, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative . . .
Posted on 1/3/19
Achillion Appoints Nicole Vitullo To Chair the Board of Directors
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders
Posted on 1/2/19
FCLTGlobal Appoints New Members to Board of Directors
FCLTGlobal, a not-for-profit organization that works to encourage a longer-term focus in business and investment decision-making
Posted on 1/2/19
NIKE Names G. Scott Uzzell CEO of Converse
NIKE, Inc. (NYSE: NKE) announced today that effective Jan. 22, 2019, G. Scott Uzzell will become President & CEO of Converse, Inc.
Posted on 1/1/19
Star Group Announces Sudden Passing of CEO Steven Goldman
Star Group, L.P. (NYSE:SGU), a home energy distributor and services provider, is saddened to announce that Steven J. Goldman
Posted on 12/21/18
Massachusetts Competitive Partnership Names Jay Ash CEO
Robert L. Reynolds, Chairman of the Massachusetts Competitive Partnership (MACP), announced today that Jay Ash will become the next chief executive officer
Posted on 12/21/18
BJ’s Wholesale Club Names Christopher Peterson to Board of Directors
Bj’s Wholesale Club Holdings, Inc. (NYSE: BJ) today announced that Christopher H. Peterson, executive vice president, Chief Financial Officer, Newell Brands
Posted on 12/21/18
WEX Appoints Susan Sobbott to Board of Directors
WEX Inc. (NYSE: WEX), a leading provider of corporate payment solutions, today announced that Susan Sobbott, a respected veteran of the global payments space
Posted on 12/20/18
Cerevel Therapeutics Expands Its Board of Directors
Cerevel Therapeutics, a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS) founded by Bain Capital
Posted on 12/20/18
Jnana Therapeutics Expands Board of Directors and Forms Scientific Advisory Board
Jnana Therapeutics today announced the appointment of two new members to its Board of Directors: Stuart Schreiber, Ph.D., a co-founder of Jnana Therapeutics
Posted on 12/20/18
Kaleido Biosciences Announces Appointment of New Members to its Board of Directors
LEXINGTON, Mass.--(BUSINESS WIRE)--Kaleido Biosciences, a healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ, today announced the appointment of three . . .
Posted on 12/20/18
MegaFood Appoints Andy Dahlen CEO
Andy Dahlen is joining MegaFood as the company's new CEO. Andy is a proven business leader with deep experience in growing
Posted on 12/20/18
TCR2 Therapeutics Appoints Andrew Allen to Board
TCR2 Therapeutics Inc., an innovative immunotherapy company developing the next generation of novel T cell receptor (TCR) therapies for patients suffering from cancer
Posted on 12/20/18
CIRCOR International Elects Samuel R. Chapin to Board of Directors
BURLINGTON, Mass.--(BUSINESS WIRE)--CIRCOR International, Inc. (NYSE: CIR), a leading provider of flow control solutions and other highly engineered products for the Industrial, Energy and Aerospace & . . .
Posted on 12/20/18
John H. Johnson to Become CEO of Melinta Therapeutics
NEW HAVEN, Conn., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial . . .
Boston
